【India】EPS of These 3 Stocks Surged Up to 173%; List Includes Companies from Jewellery to Pharma, Keep These Stocks on Your Radar

Editor’s Note

This article highlights the importance of Earnings Per Share (EPS) as a key indicator of a company’s profitability and financial strength. A rising EPS often signals improved operations and can be a driver for long-term share price appreciation.

173% तक उछला इन 3 शेयरों का EPS, लिस्ट में ज्वेलरी से लेकर फार्मा तक की कंपनियां, रडार पर रखें स्टॉक्स
EPS Surge

In the stock market, EPS (Earnings Per Share) is a crucial metric for investors. It indicates how much profit a company is earning per share. An increase in EPS signifies that the company’s earnings are improving, operations are becoming stronger, and its financial health is getting better. Consistent EPS growth signals that the company is creating long-term value, which can also lead to a rise in the share price. Let’s look at some stocks that have shown tremendous EPS growth recently and could be added to investors’ watchlists.

Thangamayil Jewellery

Thangamayil Jewellery is a well-known jewellery retail chain in South India. It started as a small store in Madurai and today the company has over 65 stores and an online jewellery platform. The company sells gold, silver, diamond, and platinum jewellery, with a large portion of its business linked to gold.
In Q3 FY26, the company’s revenue growth was 113 percent, with sales reaching approximately ₹2,406 crore. Net profit surged 119 percent to ₹105 crore. EPS for this quarter stood at ₹33.71, which is about 117 percent higher than last year’s ₹15.50.
As of January 29, its share price was ₹3,593.80.

Laurus Labs
Republic Day 2026: परेड में छाया मेक इन इंडिया टैंक, मिसाइल और ड्रोन ने बढ़ाया देश का मान; तस्वीरों में देखें

Laurus Labs Limited is a major pharmaceutical company manufacturing drugs and APIs. The company produces generic medicines and active pharmaceutical ingredients for therapies related to HIV, diabetes, heart diseases, and cancer, among others. Additionally, the company provides contract manufacturing and biotech solutions.
In Q3 FY26, the company’s income increased by 26 percent to approximately ₹1,778 crore. Meanwhile, net profit saw a sharp jump of 171 percent, reaching ₹252 crore. EPS for this quarter was ₹4.66, which is about 173 percent higher than last year’s ₹1.71.
As of January 29, its share price was ₹999.

MCX

Multi Commodity Exchange of India (MCX) is the country’s leading commodity derivatives exchange. It facilitates online trading in bullion, metals, energy, and agricultural commodities. MCX has also partnered with global exchanges like CME, LME, and EEX, promoting knowledge sharing and integration at the international level.
In Q3 FY26, the company’s income surged 121 percent to ₹666 crore. Net profit jumped 151 percent to ₹401 crore. During this period, EPS was ₹15.73, which is about 150 percent higher than last year’s ₹6.28.
As of January 29, its share price was ₹2,593.

उदय कोटक, अशोक खड़े समेत 4 बिजनेस लीडर को मिला पद्म पुरस्कार; बैंकिंग, सोलर व इंजीनियरिंग सेक्टर से नाता
Full article: View original |
⏰ Published on: January 29, 2026